For a hemodialysis patient with cellulitis over the arm containing the arteriovenous fistula, should I use that arm for dialysis, and what is the appropriate antibiotic regimen and fistula management?

Management of Cellulitis Over an Arm with Arteriovenous Fistula

You can and should continue dialysis through the arteriovenous fistula while treating the cellulitis with antibiotics, but you must avoid cannulating directly through or near the infected tissue. 1

Dialysis Access Management During Active Infection

• Continue using the fistula for dialysis during antibiotic treatment, as infected AVFs can typically be salvaged medically unlike infected grafts which often require surgical intervention 1
• Place needles in unaffected portions of the fistula away from any area showing erythema, warmth, tenderness, drainage, or compromised skin integrity 1
• Never cannulate through infected tissue as this exacerbates the infection and risks permanent access failure 1
• If the infected area is so extensive that safe cannulation sites cannot be identified, establish temporary alternative access with a tunneled central venous catheter (not a PICC line) rather than abandoning the fistula 1
• Avoid PICC lines in dialysis patients as they are associated with 2.8-fold increased odds of AVF failure (OR 2.8,95% CI 1.5-5.5) 2

Antibiotic Regimen

• Treat as subacute bacterial endocarditis with 6 weeks of IV antibiotic therapy 1
• Initial empiric coverage must include both Gram-negative and Gram-positive organisms, including Enterococcus, until culture results guide definitive therapy 1
• Obtain blood cultures before initiating antibiotics and repeat periodically during and immediately after therapy 1
• Monitor for systemic signs: persistent fever, chills, or bacteremia beyond 36 hours warrant reassessment of the treatment plan 1

Critical Distinction: AVF vs AVG Infections

This distinction is paramount for management decisions:

• Native AVF infections can be salvaged with antibiotics alone (6-week course) in most cases 1
• Synthetic graft (AVG) infections require antibiotics PLUS surgical intervention with incision/resection of the infected graft portion, or total graft resection for extensive infection 1
• Prosthetic grafts have a 22% infection rate versus only 4.3% for autogenous fistulas (p < 0.0001), and 43.8% of infected prosthetic grafts require removal 3

Indications for Fistula Takedown

Fistula takedown is mandatory only in specific circumstances:

• Septic emboli (absolute indication for surgical removal) 1, 4
• Monomelic ischemic neuropathy (immediate AVF closure required) 1, 4
• Severe symptomatic ischemia with tissue necrosis (fingertip necrosis or gangrene) 4
• Uncontrolled infection at the AV anastomosis with systemic sepsis despite appropriate antibiotics 4
• Metastatic infectious complications from access-related bacteremia may necessitate complete access removal 4

Monitoring Protocol During Treatment

• Assess the access at every dialysis session for changes in thrill, bruit, or new signs of infection spread 1
• Examine for local progression: increased erythema, purulent drainage, skin breakdown, or expanding area of involvement 1
• Monitor systemic response: resolution of fever within 36-48 hours, improvement in white blood cell count, and negative repeat blood cultures 1
• Physical examination remains the hallmark for assessing infection, though duplex ultrasound can be used as an adjunctive diagnostic technique to confirm extent of involvement and exclude pseudoaneurysm or abscess formation 2

Common Pitfalls to Avoid

• Do not delay initiating the full 6-week antibiotic protocol even for minor signs of AVF infection, as delay can lead to permanent access loss or systemic complications 1
• Do not confuse AVF management with AVG management—infected grafts almost always require surgical intervention, while infected fistulas can usually be salvaged medically 1
• Do not use the contralateral arm unnecessarily if safe cannulation sites exist in the affected arm away from infection, as this preserves future access options 1
• Do not place a PICC line for temporary access as this significantly increases risk of future AVF failure 2

Alternative Access Considerations

• If temporary alternative access is needed, use a tunneled catheter in the contralateral internal jugular vein rather than the ipsilateral side to preserve venous anatomy 2
• Central venous catheters promote chronic inflammatory state, create ongoing risk of bloodstream infection, and increase both mortality and cost compared to functioning fistulas 2
• Once the infection resolves and the new access matures (if created), the original fistula can be reassessed for continued use 5